Company Information
Industry 制造业
Company Introduction 湖南尔康制药股份有限公司是一家完全按照GMP标准和管理的现代化制药企业,主要业务包括药用辅料及新型抗生素产品.其主要产品为甘油、蓖麻油、稀盐酸、醋酸、甲醛溶液、松节油、浓氨溶液、磺胺、嘧啶银、枸橼酸钠、硫酸锌、高锰酸钾、硫酸铜、无水碳酸钠、硝酸银、弱蛋白银、甘油(供注射用)、丙二醇、三氯甲烷、乙醇、盐酸、枸橼酸、苯甲酸钠、氢氧化钠、黄凡士林、白凡士林、焦亚硫酸钠、亚硫酸氢钠、无水亚硫酸钠等等.公司是国内品种最全、规模最大的专业药用辅料生产企业之一,并且是国内少数几家拥有新型青霉素类抗生素--磺苄西林钠原料药和成品药注册批件的企业之一。
Main Business 辅料、原料药、成品药的生产和销售
Legal Representative 孙庆荣
Top Executives
董事长:帅放文
董事:孙庆荣,赵寻,施湘燕
独立董事:蒋悟真,王军文,谭雪
Top 5 Shareholder
Shareholder name Nature Holding Date
帅放文限售股+流通A股41.38%31/03/2024
湖南帅佳投资有限公司流通A股6.45%31/03/2024
彭杏妮流通A股2.54%31/03/2024
湖南金阳投资集团有限公司流通A股1.39%31/03/2024
黎壮宇流通A股1.02%31/03/2024
Company Secretary 顾吉顺
Solicitors 湖南启元律师事务所
Auditors 天健会计师事务所(特殊普通合伙)
Tel No 0731-83282597
Fax No 0731-83282705
Website www.hnerkang.com
Email 300267@hnerkang.com;luolang@hnerkang.com;fanyi@hnerkang.com
Company Address
Register: 浏阳经济技术开发区康平路167号
Office: 湖南省长沙市浏阳经济技术开发区康平路167号
Listing Date 27/09/2011
Shares Capital
Shares Capital: 2,062,604,870
Total A Share: 2,062,604,870
Listed A Share: 1,422,396,841
Non-tradable A Share: 640,208,029
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ -0.095
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 2.345
Market Capitalization(RMB) 3.414B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.